SPTSprout Social, Inc.

Nasdaq sproutsocial.com


$ 33.73 $ -0.70 (-2.03 %)    

Friday, 07-Jun-2024 15:59:58 EDT
QQQ $ 462.76 $ -0.41 (-0.09 %)
DIA $ 388.38 $ -0.84 (-0.22 %)
SPY $ 533.54 $ -0.65 (-0.12 %)
TLT $ 91.51 $ -1.71 (-1.83 %)
GLD $ 211.60 $ -7.83 (-3.57 %)
$ 33.74
$ 34.19
$ 0.00 x 0
$ 0.00 x 0
$ 33.35 - $ 34.54
$ 25.68 - $ 68.41
838,591
na
1.9B
$ 1.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-sprout-social-maintains-55-price-target

Needham analyst Scott Berg reiterates Sprout Social (NASDAQ:SPT) with a Buy and maintains $55 price target.

Core News & Articles
Market-Moving News for May 21st
05/21/2024 12:42:13

BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatou...

 sprout-social-says-currently-there-is-no-process-in-place-to-sell-or-take-co-private

https://www.sec.gov/ix?doc=/Archives/edgar/data/1517375/000151737524000075/spt-20240520.htm

 sprout-socials-founders-in-talks-to-take-company-private-sources-say

- Reuters Exclusive

 needham-reiterates-buy-on-sprout-social-maintains-55-price-target

Needham analyst Scott Berg reiterates Sprout Social (NASDAQ:SPT) with a Buy and maintains $55 price target.

 goldman-sachs-maintains-neutral-on-sprout-social-lowers-price-target-to-44

Goldman Sachs analyst Chris Merwin maintains Sprout Social (NASDAQ:SPT) with a Neutral and lowers the price target from $80 ...

 why-sprout-social-shares-got-crushed-friday

Shares of Sprout Social fell Friday after reporting first-quarter financial results Thursday and sharing Q2 guidance.Cloud soft...

 canaccord-genuity-maintains-buy-on-sprout-social-lowers-price-target-to-50

Canaccord Genuity analyst David Hynes maintains Sprout Social (NASDAQ:SPT) with a Buy and lowers the price target from $70 t...

 morgan-stanley-maintains-equal-weight-on-sprout-social-lowers-price-target-to-49

Morgan Stanley analyst Elizabeth Porter maintains Sprout Social (NASDAQ:SPT) with a Equal-Weight and lowers the price target...

 cantor-fitzgerald-maintains-overweight-on-sprout-social-lowers-price-target-to-46

Cantor Fitzgerald analyst Brett Knoblauch maintains Sprout Social (NASDAQ:SPT) with a Overweight and lowers the price target...

 barclays-maintains-overweight-on-sprout-social-lowers-price-target-to-50

Barclays analyst Raimo Lenschow maintains Sprout Social (NASDAQ:SPT) with a Overweight and lowers the price target from $72 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION